Yes, Eylea is covered by Medicare Part B. Because a retina specialist or ophthalmologist injects the drug during an office visit, it falls under Part B rather than Part D prescription drug coverage. After you meet the $283 annual Part B deductible in 2026, you owe 20% coinsurance on both the drug and the injection procedure, which comes to several hundred dollars per injection on a drug that runs around $1,800 a dose.1CMS. 2026 Medicare Parts A and B Premiums and Deductibles2American Academy of Ophthalmology. Expensive Drugs
Why Part B and Not Part D
Medicare splits drug coverage by where you take the medication. Drugs you take at home are Part D. Drugs a clinician administers in a medical setting are Part B. Eylea is injected directly into the eye in a doctor’s office, so the provider buys the drug, gives you the shot, and bills Medicare for both.3CGS Medicare. J0178 Aflibercept/Eylea Fact Sheet
The higher-dose version, Eylea HD (aflibercept 8 mg), is also covered under Part B. The manufacturer reports that 100% of Medicare Fee-for-Service beneficiaries have first-line access to Eylea HD with no prior authorization or step therapy required.4Eylea HD. Coverage – EYLEA HD (aflibercept) Injection
Which Conditions Medicare Will Pay For
Coverage applies when the injection is medically necessary for one of the approved retinal conditions:
- Wet age-related macular degeneration
- Diabetic macular edema
- Macular edema following retinal vein occlusion
- Diabetic retinopathy at stages where anti-VEGF treatment is appropriate
Your physician has to document the diagnosis and explain why Eylea is the right choice. Every Medicare claim has to meet a “reasonable and necessary” standard, and a thin chart or a mismatched diagnosis code is a common reason a claim stalls or gets denied.
How Often Medicare Will Cover an Injection
Medicare limits coverage to one injection per eye every four weeks, no matter which anti-VEGF drug is used. Alternating drugs every two weeks to get around that limit is explicitly not covered.3CGS Medicare. J0178 Aflibercept/Eylea Fact Sheet
Typical schedules by condition:
- Wet AMD: every four weeks for the first three months, then usually every eight weeks. Some patients stay monthly after the loading phase.
- Retinal vein occlusion: every four weeks on an ongoing basis.
- Diabetic macular edema and diabetic retinopathy: every four weeks for the first five injections, then every eight weeks.
Most patients end up with somewhere between six and thirteen injections per eye per year, which is what makes the cost math add up.3CGS Medicare. J0178 Aflibercept/Eylea Fact Sheet
What You Actually Pay Under Original Medicare
You first pay the $283 Part B deductible for 2026. After that, you owe 20% of the Medicare-approved amount for the drug and 20% for the injection procedure.1CMS. 2026 Medicare Parts A and B Premiums and Deductibles5Medicare. Costs
The drug is the big line. With Eylea estimated around $1,800 per dose, 20% is roughly $360 per injection before the procedure fee is added. A patient getting eight injections in a year would face close to $3,000 in drug coinsurance alone. One study found Medicare beneficiaries without supplemental coverage paid an average of about $1,046 per year in Eylea-related out-of-pocket costs, though that figure moves a lot with injection count.6NCBI. Medicare Part B Spending on Macular Degeneration Treatments Associated With Manufacturer Payments to Ophthalmologists
One boundary worth knowing: Eylea does not appear on CMS’s list of Part B drugs with reduced coinsurance under the Inflation Reduction Act’s inflation rebate program for 2026. Your coinsurance stays at the standard 20%.
Where You Get the Shot Changes the Bill
The procedure fee depends heavily on setting. Using Medicare’s 2026 national averages, the coinsurance for the injection itself runs about $27 in a doctor’s office or ambulatory surgical center versus about $82 in a hospital outpatient department.7Medicare. Procedure Price Lookup for Outpatient Services – 67028 Across a year of injections, choosing an office-based retina specialist over a hospital-affiliated clinic can save a few hundred dollars.
How Supplemental Coverage Changes the Number
Medigap exists for exactly this kind of recurring coinsurance. Plans C, D, F, and G cover 100% of the Part B coinsurance, so once the deductible is met your per-injection out-of-pocket cost drops to zero. Monthly premiums for Plan G generally run from around $125 to $270 depending on location and age, and that premium pays for itself quickly when you’re getting several high-cost injections a year.8Medicare. Learn What Medigap Covers
If you’re in a Medicare Advantage plan instead, the plan must still cover Eylea when medically necessary, but it sets its own copayment or coinsurance and may require in-network providers. Some Advantage plans charge less than 20% on specialty drugs; others charge more. The specific amounts live in your plan’s Evidence of Coverage.9HHS.gov. What Is Medicare Part C
A timing warning if you’re thinking about switching from Advantage to Original Medicare plus Medigap for predictable Eylea coverage: federal law gives you a guaranteed-issue right to buy Medigap only during limited windows. If you joined an Advantage plan when you first turned 65, you can switch and buy any Medigap plan within your first year. After that trial period, Medigap insurers in most states can deny you or charge more based on pre-existing conditions like macular degeneration.
Step Therapy and Prior Authorization in Advantage Plans
Original Medicare Fee-for-Service does not require prior authorization for standard Eylea injections. Medicare Advantage plans can, and this is where coverage questions often turn into coverage fights.
Step therapy means the plan requires a cheaper option first and documentation that it didn’t work. Some Advantage plans designate bevacizumab (Avastin), at roughly $70 per dose, as the preferred first-line anti-VEGF, requiring a trial before approving Eylea at around $1,800. In some cases the plan may require an inadequate response to two preferred drugs before approving Eylea.10eCFR. 42 CFR 422.136 Medicare Advantage (MA) and Step Therapy for Part B Drugs
If your retina specialist believes Eylea is the right drug from the start, the plan has to offer an exceptions process. Your doctor can request a step therapy exception by documenting a contraindication to the preferred drug, a previous failed trial, or clinical evidence supporting Eylea. Starting January 1, 2026, Advantage plans must process prior authorization requests within seven calendar days, down from fourteen.
Ask specifically about Eylea HD if you’re in an Advantage plan. The manufacturer reports that about 87% of patients who had benefits verified for both Eylea and Eylea HD received identical coverage outcomes, which still leaves a meaningful share facing different requirements for the higher-dose version.4Eylea HD. Coverage – EYLEA HD (aflibercept) Injection
Help With the Coinsurance
If you’re on Original Medicare without Medigap and 20% is still a barrier, there are a few routes:
- Eylea4U, the manufacturer’s patient assistance program, can provide Eylea at no cost to eligible underinsured patients. Both Medicare Fee-for-Service and Medicare Advantage patients can enroll, with coverage lasting through the end of the calendar year. Income limits apply. The commercial copay card is not valid for anyone covered by Medicare or any other federal program.11Eylea HD. Financial Assistance
- Independent charitable foundations run copay grants for Medicare patients with retinal conditions, including the Patient Access Network Foundation, Good Days, and the HealthWell Foundation. Funding opens and closes, so apply early.12The American Society of Retina Specialists. Patient Assistance Programs
- If you qualify for both Medicare and Medicaid, state Medicaid generally covers your Part B cost-sharing, which can reduce or eliminate what you owe for Eylea.
Your retina specialist’s office usually has a billing coordinator who knows these programs. Ask before your first injection, not after the first bill arrives.
If a Claim Gets Denied
Original Medicare gives you a five-level appeals process, and most denials come from documentation gaps rather than a true coverage problem, so the first level often fixes it. You start with a redetermination filed with the Medicare Administrative Contractor by the deadline on your Medicare Summary Notice, with a decision typically within 60 days. If that fails, you have 180 days to request reconsideration by a Qualified Independent Contractor, then options for an Administrative Law Judge hearing, Medicare Appeals Council review, and federal district court.13Medicare. Appeals in Original Medicare
The strongest appeals include a detailed letter from your retina specialist explaining why Eylea is medically necessary for your specific condition, backed by clinical records like OCT imaging and visual acuity measurements.14Medicare. Filing an Appeal